Skip to content

Deferred registration: Fortrea code 780279

Deferred registration: Fortrea code 780279 [Full scientific title to be added on or before the deferral expiry date]

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN48262326
Enrollment
16
Registered
2026-07-03
Start date
2026-08-28
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date Other

Interventions

Sponsors

Sanofi (France)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 1 Years

Inclusion criteria

Inclusion criteria: The Health Research Authority has approved a deferral. Full details will be added to the trial record (including age limits) on or before the deferral expiry date

Exclusion criteria

Exclusion criteria: The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date

Design outcomes

Primary

MeasureTime frame
The Health Research Authority has approved a deferral. Full details will be added to the trial record on or before the deferral expiry date. [Outcome] measured using [measure] at [timepoint]

Countries

England, United Kingdom

Contacts

Public ContactBenjamin Monaghan
benjamin.monaghan@fortrea.com+44 (0) 113 301 3512

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jul 23, 2026